Nik Misljencevic

Director Business Development & Transactions AbCellera

Seminars

Thursday 10th September 2026
Finding a Gap: Achieving Good Response Rates in Difficult Tumor Types
3:00 pm
  • How do established payloads compare in their ability to drive meaningful clinical responses?
  • Have historically pursued targets lacked sufficient expression or accessibility to enable effective tumor penetration?
  • What role can mechanisms play in increasing efficacy?
Nik Misljencevic speaker at Oncology & Immunology Innovation Partnering